HCM Academy, CME on hypertrophic cardiomyopathy

14 July 2022

Hypertrophic cardiomyopathy (HCM) is a genetic condition that can affect as many as 1 in 200 people. The HCM Academy is a cardiology programme created and launched in November 2021 by PCM Scientific. It provides free peer-to-peer CME courses developed to bring quality best practice care and recognition of HCM in patients.

With 40 live digital workshops delivered by leading experts to date, the programme has now been extended until the end of October 2022. Not only does the HCM Academy provide live digital workshops, but it also offers online educational activities to enhance learning and provide free education and insight around the recognition and management of HCM.

These free CME modules and case studies allow users to learn directly from leading HCM experts and hear from HCM patients about their experiences.

“It is my pleasure to introduce the HCM Academy to you, this is a unique program that has been painstakingly put forth by the HCM Academy. The whole purpose is to introduce a broad group of healthcare providers, including family practitioners, internal medicine, and APPs, to this exciting disease called HCM…. There are about 600,000 patients [in the US] that may or may not know they have HCM. So, there is a lot of work to do, and the front-line physicians are crucial in the fight against this disease. I sincerely hope you enjoy the program and sign up for additional sessions because there is a lot of good material there.” Milind Desai – Regional Leader, The HCM Academy

The HCM Academy is developed in partnership with and endorsed by the HCMA and targets our community of family practitioners, primary care physicians, nurse practitioners, advanced practice providers, GPs, internists, and community cardiology teams across the United States of America.